Posts

Kessler Foundation receives $725,000 grant for study to...

East Hanover, NJ – September 12, 2023 – Carly Wender, PhD, associate research sc...

Freshwater connectivity can transport environmental DNA...

A new paper published in the journal Proceedings of the Royal Society B used env...

Moderna Forms Multi-Billion Dollar Strategic Partnershi...

Moderna has entered into a significant research partnership with Immatics, focus...

Janssen seeks EMA authorisation for urothelial cancer t...

Janssen has filed a marketing authorisation application with the European Medici...

Alexion and Verge enter AI-powered drug discovery deal

Alexion has entered into a partnership with Verge Genomics to detect new drug ta...

Sandoz partners with Samsung Bioepis to license Stelara...

The agreement allows Sandoz exclusive marketing rights for the inflammatory bowe...

Pharmaceutical Technology Excellence Awards 2023: Viedoc

Viedoc is a Category Award Winner for Innovation and Product Launches in the 202...

Verona Pharma’s ensifentrine inches closer to approval ...

The agency has set a PDUFA target action date to June 2024, with no current plan...

Why prefilled vial capacity is key to a competitive edg...

With many biopharma companies outsourcing for manufacturing support, how can you...

Signal: Kroger to pay up to $1.4bn to settle opioid cri...

Kroger's settlement, alongside the review of the Purdue Pharma bankruptcy case, ...

Coherus acquires immuno-oncology company Surface

Coherus BioSciences has concluded the acquisition of immuno-oncology (I-O) compa...

Grit Biotechnology secures funds for development of pip...

Grit Biotechnology has secured more than $60m in a Series B funding round to sup...

Biosyngen receives FDA approval to start Phase I trial ...

The US FDA has awarded Biosyngen’s IND for the T-cell receptor therapy, BRL03, t...

Six-year follow-up data on CheckMate 227 survival and q...

[Singapore — 10:35 a.m. SGT–September 10, 2023) — The International Association ...

Amid another rise in cases, Covid’s new normal has set in

While the angst over another rise in Covid cases is understandable, there’s some...

STAT+: Crinetics acromegaly drug succeeds in late-stage...

Crinetics Pharmaceuticals announced its experimental drug for acromegaly succeed...